ChemoTech and ABEX/Gold Lite Group expand its cooperation into Vietnam
Today the ABEX/Gold Lite Group has exercised its option to represent ChemoTech and IQwave™ also in Vietnam. Through this agreement ChemoTech receives an additional order amounting to 17 000 EURO.
This is the second agreement signed by the two companies in just a few day and it strengthens the geographical cooperation as well as the synergies it gives to ChemoTech working with a large regional distributor.
Vietnam is a large country with a about 90 million inhabitants, where more than 150 000 people are diagnosed with cancer yearly. Because of limited knowledge and lack of access to medical treatment, 75 000 Vietnamese die in this terrible disease every year.
- ”We are very glad to inform that IQwave™ soon will be made available to help many of the cancer patients in Vietnam.” says Mohan Frick, CEO of ChemoTech.
The ABEX/Gold Lite Group is a larger corporation specialised in imaging and oncology with its own organisations in Singapore, Malaysia, Vietnam, Myanmar, Thailand and Brunei.
The payment for the order of 17 000 EURO will be completed when the IQwave™ has secured its CE mark.
Certified Adviser: Västra Hamnen Corporate Finance AB, Tel: +46 40 200 250,
E-mail: ca@vhcorp.se
For more information, please contact:
Mohan Frick, CEO
Tel: +46 (0)10-218 93 00
This information is such information which Scandinavian ChemoTech AB (publ) are obligated to make public according to EU’s market abuse regulation and the law of securities market. The information was submitted by the agency of above stated contact person, to be made public on Monday February 18th 2019 at 13.15 (CET).
Scandinavian ChemoTech AB (publ)
www.chemotech.seChemoTech is a life science company that possesses great medical expertise and technical knowledge. Our latest Product IQwave™ is an innovation within electroporation, specifically design for Electrochemotherapy for the treatment of different types of tumors. ChemoTech strives to contribute to a more accessible cancer care. ChemoTech's shares (CMOTEC B) are listed on Nasdaq First North in Stockholm and Västra Hamnen Corporate Finance AB is the company's Certified Adviser. The company is headquartered at Medicon Village in Lund Sweden, in the midst of the medical technology expansionary Oresund region.